BCS Private Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Buy
5,750
+2,700
+89% +$963K 0.61% 43
2025
Q4
$998K Buy
3,050
+100
+3% +$31.7K 0.34% 61
2025
Q3
$832K Hold
2,950
0.3% 64
2025
Q2
$824K Buy
+2,950
New +$836K 0.31% 64

Other funds holding AMGN

BCS Private Wealth Management's AMGN Position: Q1 2026 in Review

BCS Private Wealth Management increased its Amgen (AMGN) stake by 89% in Q1 2026, buying an estimated $963K and bringing the position to 5,750 shares worth $2.02M. The position accounts for 0.61% of the portfolio, ranked #43.

BCS Private Wealth Management first reported a position in AMGN in Q2 2025 and has held it in 4 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • BCS Private Wealth Management held 5,750 shares of Amgen worth $2.02M as of Q1 2026.
  • BCS Private Wealth Management bought 2,700 Amgen shares in Q1 2026, an estimated $963K.
  • Amgen made up 0.61% of BCS Private Wealth Management's portfolio in Q1 2026, its #43 holding.
  • BCS Private Wealth Management first reported a position in Amgen in Q2 2025 and has held it in 4 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on BCS Private Wealth Management's 13F filing for Q1 2026, filed 21 Apr 2026.